The role of estrogen in bone growth and formation: Changes at puberty

Cell Health and Cytoskeleton

Volumn 3, Issue 1, 2011, Pages 2-12

  Singh, Divya ^a   Sanyal, Sabyasachi ^b   Chattopadhyay, Naibedya ^a  

^a Central Drug (Institute Council of Scientific and Industrial Research)   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Estrogen; Growth plate; Peak bone mass; Puberty

Indexed keywords

AROMATASE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GROWTH HORMONE; SEX HORMONE; SOMATOMEDIN C; TESTOSTERONE;

AROMATIZATION; BONE CELL; BONE GROWTH; BONE MASS; BONE STRENGTH; DIETARY INTAKE; EPIPHYSIS; GENE MUTATION; GROWTH ACCELERATION; GROWTH HORMONE RELEASE; GROWTH INHIBITION; GROWTH PLATE; HUMAN; LONG BONE; NONHUMAN; OSSIFICATION; PROTEIN LOCALIZATION; PUBERTY; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION;

MUS;

EID: 79952684450     PISSN: None     EISSN: 11791330     Source Type: Journal    
DOI: 10.2147/CHC.S8916     Document Type: Review

References (130)

1. Tuck SP, Francis RM. Osteoporosis. Postgrad Med J. 2002; 78(923):526-532.
2. Cooper C, Emkey RD, McDonald RH, et al. Efficacy and safety of oral weekly ibandronate in the treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab. 2003;88(10):4609-4615.
3. Bonjour JP, Ammann P, Chevalley T, Rizzoli R. Protein intake and bone growth. Can J Appl Physiol. 2001;26 Suppl:S153-S166.
4. Bonjour JP, Chevalley T, Ferrari S, Rizzoli R. The importance and relevance of peak bone mass in the prevalence of osteoporosis. Salud Publica Mex. 2009;51 Suppl 1:S5-S17.
5. Theintz G, Buchs B, Rizzoli R, et al. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab. 1992;75(4): 1060-1065.
6. Melton LJ 3rd, Looker AC, Shepherd JA, et al. Osteoporosis assessment by whole body region vs site-specific DXA. Osteoporos Int. 2005; 16(12):1558-1564.
7. Bass S, Delmas PD, Pearce G, Hendrich E, Tabensky A, Seeman E. The differing tempo of growth in bone size, mass, and density in girls is region-specific. J Clin Invest. 1999;104(6):795-804.
8. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994;4(6):368-381.
9. Hansen MA, Overgaard K, Riis BJ, Christiansen C. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study. BMJ. 1991;303(6808):961-964.
10. Briot K, Roux C. What is the role of DXA, QUS and bone markers in fracture prediction, treatment allocation and monitoring? Best Pract Res Clin Rheumatol. 2005;19(6):951-964.
11. Ferrari S, Manen D, Bonjour JP, Slosman D, Rizzoli R. Bone mineral mass and calcium and phosphate metabolism in young men: relationships with vitamin D receptor allelic polymorphisms. J Clin Endocrinol Metab. 1999;84(6):2043-2048.
12. Ferrari S, Rizzoli R, Manen D, Slosman D, Bonjour JP. Vitamin D receptor gene start codon polymorphisms (FokI) and bone mineral density: interaction with age, dietary calcium, and 3′-end region polymorphisms. J Bone Miner Res. 1998;13(6):925-930.
13. Bonjour JP, Theintz G, Law F, Slosman D, Rizzoli R. Peak bone mass. Osteoporos Int. 1994;4(Suppl 1):7-13.
14. Hasegawa Y, Schneider P, Reiners C, et al. Estimation of the architectural properties of cortical bone using peripheral quantitative computed tomography. Osteoporos Int. 2000;11(1):36-42.
15. Riggs BL, Khosla S, Melton LJ 3rd. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev. 2002;23(3): 279-302.
16. Lu PW, Cowell CT, LLoyd-Jones SA, Briody JN, Howman-Giles R. Volumetric bone mineral density in normal subjects, aged 5-27 years. J Clin Endocrinol Metab. 1996;81(4):1586-1590.
17. Cadogan J, Blumsohn A, Barker ME, Eastell R. A longitudinal study of bone gain in pubertal girls: anthropometric and biochemical correlates. J Bone Miner Res. 1998;13(10):1602-1612.
18. Terasawa E, Fernandez DL. Neurobiological mechanisms of the onset of puberty in primates. Endocr Rev. 2001;22(1):111-151.
19. Magarey AM, Boulton TJ, Chatterton BE, Schultz C, Nordin BE, Cockington RA. Bone growth from 11 to 17 years: relationship to growth, gender and changes with pubertal status including timing of menarche. Acta Paediatr. 1999;88(2):139-146.
20. Vizmanos B, Martí-Henneberg C, Clivillé R, Moreno A, Fernández-Ballart J. Age of pubertal onset affects the intensity and duration of pubertal growth peak but not final height. Am J Hum Biol. 2001;13(3): 409-416.
21. Riggs BL, Khosla S, Melton LJ 3rd. The assembly of the adult skeleton during growth and maturation: implications for senile osteoporosis. J Clin Invest. 1999;104(6):671-672.
22. Duan Y, Beck TJ, Wang XF, Seeman E. Structural and biomechanical basis of sexual dimorphism in femoral neck fragility has its origins in growth and aging. J Bone Miner Res. 2003;18(10):1766-1774.
23. Seeman E. Periosteal bone formation - a neglected determinant of bone strength. N Engl J Med. 2003;349(4):320-323.
24. Seeman E. Clinical review 137: sexual dimorphism in skeletal size, density, and strength. J Clin Endocrinol Metab. 2001;86(10):4576-4584.
25. Kontulainen SA, Macdonald HM, Khan KM, McKay HA. Examining bone surfaces across puberty: a 20-month pQCT trial. J Bone Miner Res. 2005;20(7):1202-1207.
26. Seeman E. Invited review: pathogenesis of osteoporosis. J Appl Physiol. 2003;95(5):2142-2151.
27. Seeman E. Bone quality. Osteoporos Int. 2003;14(Suppl 5):S3-S7.
28. Seeman E. Pathogenesis of bone fragility in women and men. Lancet. 2002;359(9320):1841-1850.
29. Vanderschueren D, Vandenput L, Boonen S. Reversing sex steroid deficiency and optimizing skeletal development in the adolescent with gonadal failure. Endocr Dev. 2005;8:150-165.
30. Heaney RP, Abrams S, Dawson-Hughes B, et al. Peak bone mass. Osteoporos Int. 2000;11(12):985-1009.
31. Wosje KS, Specker BL. Role of calcium in bone health during childhood. Nutr Rev. 2000;58(9):253-268.
32. Masuyama R, Nakaya Y, Katsumata S, et al. Dietary calcium and phosphorus ratio regulates bone mineralization and turnover in vitamin D receptor knockout mice by affecting intestinal calcium and phosphorus absorption. J Bone Miner Res. 2003;18(7):1217-1226.
33. Estívariz CF, Ziegler TR. Nutrition and the insulin-like growth factor system. Endocrine. 1997;7(1):65-71.
34. Christoforidis A, Maniadaki I, Stanhope R. Growth hormone/ insulin-like growth factor-1 axis during puberty. Pediatr Endocrinol Rev. 2005;3(1):5-10.
35. Mauras N. Growth hormone and sex steroids. Interactions in puberty. Endocrinol Metab Clin North Am. 2001;30(3):529-544.
36. Clark PA, Rogol AD. Growth hormones and sex steroid interactions at puberty. Endocrinol Metab Clin North Am. 1996;25(3):665-681.
37. Styne DM. The regulation of pubertal growth. Horm Res. 2003;60(Suppl 1):22-26.
38. Juul A, Bang P, Hertel NT, et al. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab. 1994;78(3):744-752.
39. Albertsson-Wikland K, Rosberg S, Karlberg J, Groth T. Analysis of 24-hour growth hormone profiles in healthy boys and girls of normal stature: relation to puberty. J Clin Endocrinol Metab. 1994; 78(5):1195-1201.
40. Giustina A, Scalvini T, Tassi C, et al. Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone. J Clin Endocrinol Metab. 1997;82(4):1210-1219.
41. Marin G, Domené HM, Barnes KM, Blackwell BJ, Cassorla FG, Cutler GB Jr. The effects of estrogen priming and puberty on the growth hormone response to standardized treadmill exercise and arginine-insulin in normal girls and boys. J Clin Endocrinol Metab. 1994;79(2):537-541.
42. Leung KC, Johannsson G, Leong GM, Ho KK. Estrogen regulation of growth hormone action. Endocr Rev. 2004;25(5):693-721.
43. Juul A. The effects of oestrogens on linear bone growth. Hum Reprod Update. 2001;7(3):303-313.
44. Frank GR. Role of estrogen and androgen in pubertal skeletal physiology. Med Pediatr Oncol. 2003;41(3):217-221.
45. Meinhardt UJ, Ho KK. Modulation of growth hormone action by sex steroids. Clin Endocrinol (Oxf). 2006;65(4):413-422.
46. Chagin AS, Sävendahl L. Genes of importance in the hormonal regulation of growth plate cartilage. Horm Res. 2009;71 Suppl 2:41-47.
47. Veldhuis JD, Roemmich JN, Rogol AD. Gender and sexual maturation-dependent contrasts in the neuroregulation of growth hormone secretion in prepubertal and late adolescent males and females - a general clinical research center-based study. J Clin Endocrinol Metab. 2000;85(7):2385-2394.
48. Coutant R, de Casson FB, Rouleau S, et al. Divergent effect of endogenous and exogenous sex steroids on the insulin-like growth factor I response to growth hormone in short normal adolescents. J Clin Endocrinol Metab. 2004;89(12):6185-6192.
49. Metzger DL, Kerrigan JR, Rogol AD. Gonadal steroid hormone regulation of the somatotropic axis during puberty in humans mechanisms of androgen and estrogen action. Trends Endocrinol Metab. 1994;5(7):290-296.
50. Metzger DL, Kerrigan JR. Estrogen receptor blockade with tamoxifen diminishes growth hormone secretion in boys: evidence for a stimulatory role of endogenous estrogens during male adolescence. J Clin Endocrinol Metab. 1994;79(2):513-518.
51. Hero M, Norjavaara E, Dunkel L. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial. J Clin Endocrinol Metab. 2005;90(12):6396-6402.
52. Mauras N, Gonzalez de Pijem L, Hsiang HY, et al. Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years. J Clin Endocrinol Metab. 2008;93(3):823-831.
53. Wennink JM, Delemarre-van deWaal HA, Schoemaker R, Blaauw G, van den Braken C, Schoemaker J. Growth hormone secretion patterns in relation to LH and testosterone secretion throughout normal male puberty. Acta Endocrinol (Copenh). 1990;123(3):263-270.
54. Ho KY, Evans WS, Blizzard RM, et al. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab. 1987;64(1):51-58.
55. Winer LM, Shaw MA, Baumann G. Basal plasma growth hormone levels in man: new evidence for rhythmicity of growth hormone secretion. J Clin Endocrinol Metab. 1990;70(6):1678-1686.
56. Laron Z, Lilos P, Klinger B. Growth curves for Laron syndrome. Arch Dis Child. 1993;68(6):768-770.
57. Keenan BS, Richards GE, Ponder SW, Dallas JS, Nagamani M, Smith ER. Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty. J Clin Endocrinol Metab. 1993;76(4):996-1001.
58. Eakman GD, Dallas JS, Ponder SW, Keenan BS. The effects of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion. J Clin Endocrinol Metab. 1996;81(3):1217-1223.
59. Veldhuis JD, Metzger DL, Martha PM Jr, et al. Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement. J Clin Endocrinol Metab. 1997; 82(10):3414-3420.
60. Weissberger AJ, Ho KK. Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization. J Clin Endocrinol Metab. 1993;76(6):1407-1412.
61. Ulloa-Aguirre A, Blizzard RM, Garcia-Rubi E, et al. Testosterone and oxandrolone, a nonaromatizable androgen, specifically amplify the mass and rate of growth hormone (GH) secreted per burst without altering GH secretory burst duration or frequency or the GH half-life. J Clin Endocrinol Metab. 1990;71(4):846-854.
62. Malhotra A, Poon E, Tse WY, Pringle PJ, Hindmarsh PC, Brook CG. The effects of oxandrolone on the growth hormone and gonadal axes in boys with constitutional delay of growth and puberty. Clin Endocrinol (Oxf). 1993;38(4):393-398.
63. Crowne EC, Wallace WH, Moore C, et al. Effect of low dose oxandrolone and testosterone treatment on the pituitary-testicular and GH axes in boys with constitutional delay of growth and puberty. Clin Endocrinol (Oxf). 1997;46(2):209-216.
64. Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, Ohlsson C. Androgens and bone. Endocr Rev. 2004;25(3): 389-425.
65. Simm PJ, Bajpai A, Russo VC, Werther GA. Estrogens and growth. Pediatr Endocrinol Rev. 2008;6(1):32-41.
66. Weise M, de-Levi S, Barnes KM, Gafni RI, Abad V, Baron J. Effects of estrogen on growth plate senescence and epiphyseal fusion. Proc Natl Acad Sci U S A. 2001;98(12):6871-6876.
67. Hunziker EB, Schenk RK. Physiological mechanisms adopted by chondrocytes in regulating longitudinal bone growth in rats. J Physiol. 1989;414:55-71.
68. Simpson E, Rubin G, Clyne C, et al. Local estrogen biosynthesis in males and females. Endocr Relat Cancer. 1999;6(2):131-137.
69. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab. 1995;80(12):3689-3698.
70. Smith EP, Boyd J, Frank GR, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 1994; 331(16):1056-1061.
71. Brown TR, Lubahn DB, Wilson EM, French FS, Migeon CJ, Corden JL. Functional characterization of naturally occurring mutant androgen receptors from subjects with complete androgen insensitivity. Mol Endocrinol. 1990;4(12):1759-1772.
72. Ritzén EM. Pubertal growth in genetic disorders of sex hormone action and secretion. Acta Paediatr Suppl. 1992;383:22-25; discussion 26.
73. Conte FA, Grumbach MM, Ito Y, Fisher CR, Simpson ER. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab. 1994; 78(6):1287-1292.
74. Hochberg Z, Schechter J, Benderly A, Leiberman E, Rosler A. Growth and pubertal development in patients with congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. Am J Dis Child. 1985; 139(8):771-776.
75. Compston JE. Sex steroids and bone. Physiol Rev. 2001;81(1): 419-447.
76. Laue L, Kenigsberg D, Pescovitz OH, et al. Treatment of familial male precocious puberty with spironolactone and testolactone. N Engl J Med. 1989;320(8):496-502.
77. Bilezikian JP, Morishima A, Bell J, Grumbach MM. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med. 1998;339(9):599-603.
78. Gilsanz V, Skaggs DL, Kovanlikaya A, et al. Differential effect of race on the axial and appendicular skeletons of children. J Clin Endocrinol Metab. 1998;83(5):1420-1427.
79. Gilsanz V, Kovanlikaya A, Costin G, Roe TF, Sayre J, Kaufman F. Differential effect of gender on the sizes of the bones in the axial and appendicular skeletons. J Clin Endocrinol Metab. 1997;82(5): 1603-1607.
80. Iuliano-Burns S, Hopper J, Seeman E. The age of puberty determines sexual dimorphism in bone structure: a male/female co-twin control study. J Clin Endocrinol Metab. 2009;94(5):1638-1643.
81. Bradney M, Karlsson MK, Duan Y, Stuckey S, Bass S, Seeman E. Heterogeneity in the growth of the axial and appendicular skeleton in boys: implications for the pathogenesis of bone fragility in men. J Bone Miner Res. 2000;15(10):1871-1878.
82. Seeman E. Growth in bone mass and size - are racial and gender differences in bone mineral density more apparent than real? J Clin Endocrinol Metab. 1998;83(5):1414-1419.
83. Gilsanz V, Roe TF, Mora S, Costin G, Goodman WG. Changes in vertebral bone density in black girls and white girls during childhood and puberty. N Engl J Med. 1991;325(23):1597-1600.
84. Bryant RJ, Wastney ME, Martin BR, et al. Racial differences in bone turnover and calcium metabolism in adolescent females. J Clin Endocrinol Metab. 2003;88(3):1043-1047.
85. Windahl SH, Lagerquist MK, Andersson N, et al. Identification of target cells for the genomic effects of estrogens in bone. Endocrinology. 2007;148(12):5688-5695.
86. Kusec V, Virdi AS, Prince R, Triffitt JT. Localization of estrogen receptor-alpha in human and rabbit skeletal tissues. J Clin Endocrinol Metab. 1998;83(7):2421-2428.
87. Nilsson LO, Boman A, Sävendahl L, et al. Demonstration of estrogen receptor-beta immunoreactivity in human growth plate cartilage. J Clin Endocrinol Metab. 1999;84(1):370-373.
88. Arts J, Kuiper GG, Janssen JM, et al. Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells. Endocrinology. 1997;138(11): 5067-5070.
89. Chagin AS, Vannesjö J, Sävendahl L. Androgen receptor modulation does not affect longitudinal growth of cultured fetal rat metatarsal bones. Horm Res. 2009;71(4):219-227.
90. Ohlsson C, Vandenput L. The role of estrogens for male bone health. Eur J Endocrinol. 2009;160(6):883-889.
91. Chagin AS, Sävendahl L. GPR30 estrogen receptor expression in the growth plate declines as puberty progresses. J Clin Endocrinol Metab. 2007;92(12):4873-4877.
92. Krassas GE, Papadopoulou P. Oestrogen action on bone cells. J Musculoskelet Neuronal Interact. 2001;2(2):143-151.
93. Nakamura T, Imai Y, Matsumoto T, et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell. 2007;130(5):811-823.
94. Krum SA, Miranda-Carboni GA, Hauschka PV, et al. Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. EMBO J. 2008;27(3):535-545.
95. García Palacios V, Robinson LJ, Borysenko CW, Lehmann T, Kalla SE, Blair HC. Negative regulation of RANKL-induced osteoclastic differentiation in RAW264.7 cells by estrogen and phytoestrogens. J Biol Chem. 2005;280(14):13720-13727.
96. Komm BS, Terpening CM, Benz DJ, et al. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science. 1988;241(4861):81-84.
97. Khastgir G, Studd J, Holland N, Alaghband-Zadeh J, Fox S, Chow J. Anabolic effect of estrogen replacement on bone in postmenopausal women with osteoporosis: histomorphometric evidence in a longitudinal study. J Clin Endocrinol Metab. 2001;86(1):289-295.
98. Nasu M, Sugimoto T, Kaji H, Chihara K. Estrogen modulates osteoblast proliferation and function regulated by parathyroid hormone in osteoblastic SaOS-2 cells: role of insulin-like growth factor (IGF)-I and IGF-binding protein-5. J Endocrinol. 2000;167(2):305-313.
99. Okazaki R, Inoue D, Shibata M, et al. Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. Endocrinology. 2002;143(6): 2349-2356.
100. Zhou S, Turgeman G, Harris SE, et al. Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells. Mol Endocrinol. 2003;17(1):56-66.
101. Perry RJ, Farquharson C, Ahmed SF. The role of sex steroids in controlling pubertal growth. Clin Endocrinol (Oxf). 2008;68(1):4-15.
102. Chagin AS, Sävendahl L. Estrogens and growth: review. Pediatr Endocrinol Rev. 2007;4(4):329-334.
103. Vanderschueren D, Venken K, Ophoff J, Bouillon R, Boonen S. Clinical review: sex steroids and the periosteum - reconsidering the roles of androgens and estrogens in periosteal expansion. J Clin Endocrinol Metab. 2006;91(2):378-382.
104. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci U S A. 1993;90(23):11162-11166.
105. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development. 2000;127(19):4277-4291.
106. Pendaries C, Darblade B, Rochaix P, et al. The AF-1 activation-function of ERalpha may be dispensable to mediate the effect of estradiol on endothelial NO production in mice. Proc Natl Acad Sci U S A. 2002; 99(4):2205-2210.
107. Sims NA, Dupont S, Krust A, et al. Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males. Bone. 2002;30(1):18-25.
108. Tözüm TF, Oppenlander ME, Koh-Paige AJ, Robins DM, McCauley LK. Effects of sex steroid receptor specificity in the regulation of skeletal metabolism. Calcif Tissue Int. 2004;75(1):60-70.
109. Vidal O, Lindberg MK, Hollberg K, et al. Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. Proc Natl Acad Sci U S A. 2000;97(10):5474-5479.
110. Parikka V, Peng Z, Hentunen T, et al. Estrogen responsiveness of bone formation in vitro and altered bone phenotype in aged estrogen receptor-alpha-deficient male and female mice. Eur J Endocrinol. 2005;152(2):301-314.
111. Chagin AS, Lindberg MK, Andersson N, et al. Estrogen receptor-beta inhibits skeletal growth and has the capacity to mediate growth plate fusion in female mice. J Bone Miner Res. 2004;19(1):72-77.
112. Lindberg MK, Alatalo SL, Halleen JM, Mohan S, Gustafsson JA, Ohlsson C. Estrogen receptor specificity in the regulation of the skeleton in female mice. J Endocrinol. 2001;171(2):229-236.
113. Windahl SH, Vidal O, Andersson G, Gustafsson JA, Ohlsson C. Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. J Clin Invest. 1999;104(7): 895-901.
114. Flouriot G, Brand H, Denger S, et al. Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1. EMBO J. 2000;19(17):4688-4700.
115. Chagin A, Nilsson M, Dahlman Wright K, Sävendahl L. Remaining estrogenic activity in the man with mutated estrogen receptor alpha (ERa). Horm Res. 2006;65 Suppl 4:28.
116. Vidal O, Lindberg M, Sävendahl L, et al. Disproportional body growth in female estrogen receptor-alpha-inactivated mice. Biochem Biophys Res Commun. 1999;265(2):569-571.
117. Krege JH, Hodgin JB, Couse JF, et al. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci U S A. 1998;95(26):15677-15682.
118. Ke HZ, Brown TA, Qi H, et al. The role of estrogen receptor-beta, in the early age-related bone gain and later age-related bone loss in female mice. J Musculoskelet Neuronal Interact. 2002;2(5):479-488.
119. Windahl SH, Hollberg K, Vidal O, Gustafsson JA, Ohlsson C, Andersson G. Female estrogen receptor beta(-/-) mice are partially protected against age-related trabecular bone loss. J Bone Miner Res. 2001;16(8):1388-1398.
120. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A. 1996;93(12):5925-5930.
121. Kuiper GG, Carlsson B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 1997;138(3):863-870.
122. Paech K, Webb P, Kuiper GG, et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science. 1997; 277(5331):1508-1510.
123. Kuiper GG, Gustafsson JA. The novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS Lett. 1997;410(1):87-90.
124. Revankar CM, Cimino DF, Skl a r LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science. 2005;307(5715): 1625-1630.
125. Vidal O, Kindblom LG, Ohlsson C. Expression and localization of estrogen receptor-beta in murine and human bone. J Bone Miner Res. 1999;14(6):923-929.
126. Yakar S, Liu JL, Stannard B, et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci U S A. 1999;96(13):7324-7329.
127. Venken K, de Gendt K, Boonen S, et al. Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model. J Bone Miner Res. 2006; 21(4):576-585.
128. Ornoy A, Giron S, Aner R, Goldstein M, Boyan BD, Schwartz Z. Gender dependent effects of testosterone and 17 beta-estradiol on bone growth and modelling in young mice. Bone Miner. 1994;24(1):43-58.
129. MacGillivray MH, Morishima A, Conte F, Grumbach M, Smith EP. Pediatric endocrinology update: an overview. The essential roles of estrogens in pubertal growth, epiphyseal fusion and bone turnover: lessons from mutations in the genes for aromatase and the estrogen receptor. Horm Res. 1998;49 Suppl 1:2-8.
130. Yakar S, Rosen CJ, Beamer WG, et al. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest. 2002;110(6): 771-781.